TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID).

Simon J Crabb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.